Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on 50 States Today.
Press releases published on May 15, 2025

vTv Therapeutics Announces 2025 First Quarter Financial Results and Provides Corporate Update
Ongoing screening in CATT1 Phase 3 trial evaluating cadisegliatin in patients with type 1 diabetes (T1D) Topline Phase 3 data for cadisegliatin expected in 2H 2026 HIGH POINT, N.C., May 15, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a …

Rent the Runway to Report First Quarter 2025 Results on June 5, 2025
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Rent the Runway, Inc. (“Rent the Runway”) (Nasdaq: RENT) announced today that it expects to release its first quarter 2025 financial results for the quarter ended April 30, 2025 on Thursday, June 5, 2025, after …

Alliance Entertainment Reports Third Quarter Fiscal Year 2025 Results
Delivered $1.9M in net income, a $5.3M year-over-year improvement, showcasing strong execution and margin gains Reduced revolver debt by 25% year-over-year, strengthening balance sheet and liquidity position Direct to Consumer sales reach 35% of gross …

CORRECTING AND REPLACING - Katapult Delivers 15.4% Gross Originations and 10.6% Revenue Growth in the First Quarter, Above Outlook
Expects Growth to Accelerate In Second Quarter Reiterates 2025 Guidance PLANO, Texas, May 15, 2025 (GLOBE NEWSWIRE) -- In the press release issued by Katapult Holdings, Inc. on May 15, 2025, in the gross originations by quarter table, Q4 in FY 2024 should …

Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
Announced Global Collaboration with Novo Nordisk to Develop Oral Small Molecules for Metabolic Diseases with Over $2.2 Billion in Potential Milestone Payments On Track to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the …

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Italy CNTY-308 expected to enter IND-enabling studies in mid …

374Water Reports First Quarter 2025 Financial Results
Multiple Deployments Scheduled throughout 2025 to Showcase AirSCWO Technology Launched Waste Destruction Services and Signed RCRA Part B TSDF Partner Agreement to Expand Onsite Operations New Executive Team and Director Appointments to Drive Commercial …

Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update
LYTENAVA™ (bevacizumab gamma) on track for planned first commercial launches in Germany and the United Kingdom (UK) in Q2 CY2025 Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 in the United States ISELIN, N.J., May 15, 2025 (GLOBE …

Intermap Announces First Quarter 2025 Results
Company reports first quarter 2025 revenue growth of 153% with 28% pro-forma adjusted EBITDA margin Confirms projected 2025 revenue of $30–35 million and 28% EBITDA margin Conference call today at 5:00 pm ET to discuss results DENVER, May 15, 2025 (GLOBE …

Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del primer trimestre de 2025
- VCN-01 alcanza los criterios de valoración primarios de eficacia y seguridad para el adenocarcinoma pancreático ductal en el ensayo clínico de Fase 2b VIRAGE - - El 8 de mayo de 2025 se cerró una oferta pública que aumentó el saldo de caja de la empresa …

Paul Beaubrun Joins Forces With 'Rasin' Music Pioneer Dadi Beaubrun for 'Gade Sa Yo Fè Mwen' Remix
NEW YORK, NY, UNITED STATES, May 15, 2025 /EINPresswire.com/ -- “Growing up watching my uncle, Daniel ‘Dadi’ Beaubrun, perform on stage with my parents in Boukman Eksperyans was something special,” says Paul Beaubrun, the Haitian Rasin/Rock artist. “As …

Physician Reveals Concerning Trend in Health Care Pricing and What Can Be Done About It
LA, UNITED STATES, May 15, 2025 /EINPresswire.com/ -- Surveys show most doctors are increasingly concerned about a trend in health care pricing; patients being charged more for the same service, depending on where they go. And most don’t even know it’s …

Bakkt INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bakkt Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

IBTA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ibotta, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …

PPTA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Perpetua Resources Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

RKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rock Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

UNH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UnitedHealth Group Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

Eric Branderiz Joins Symbotic’s Board of Directors
WILMINGTON, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, today announced the election of Eric Branderiz to its Board of Directors, effective May 14, 2025. Mr. …

Molecular Partners Reports Financial Results and Highlights from Q1 2025
Clinical programs on track, with two major milestones later this year, and cash position, CHF 131 million as of March 31, 2025, expected to provide funding well into 2027 IND filing and initial clinical data on first targeted Radio-DARPin therapy program, …